The FDA urges healthcare professionals to stop administering the products, and patients should stop using them.

A fresh wave of disinformation about vaccines is flaring amid the 2024 campaign. The FDA's top vaccine official believes ...

Journey Medical said on Monday the U.S. Food and Drug Administration has approved its drug for the treatment of a long-term ...

Journey Medical (DERM) announced that the FDA has approved Emrosi, formerly referred to as DFD-29, for the treatment of inflammatory lesions of ...

NeurAxis (NYSE:NRXS) announced today that the FDA granted an expanded 510(k) clearance for its IB-Stim non-implanted nerve ...

The rules we've established for pharma ads on TV and radio don't apply to ads on social media. That needs to change.

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

High costs push patients to cheaper compounded versions sold online Doctors report intense demand but insurance coverage and supply issues persist FDA allows continued compounding of drugs despite ...

Eponyms — diseases named after a person — can cause serious confusion. That is particularly true in one rare disease community.